<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03498729</url>
  </required_header>
  <id_info>
    <org_study_id>16-005678</org_study_id>
    <secondary_id>1K01HL135288-01</secondary_id>
    <nct_id>NCT03498729</nct_id>
  </id_info>
  <brief_title>Autoimmunity in the Pathogenesis of AF</brief_title>
  <official_title>The Role of Autoimmune Mechanisms in the Pathogenesis of Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study is being done to find out whether autoimmune mechanisms are associated
      with the development of atrial fibrillation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study sets out to identify an explanation for the pathogenesis of AF, potentially forming
      the basis for designing novel targeted therapies to prevent or reverse this prevalent human
      disease. The overall objectives are to determine whether autoimmune diseases are associated
      with AF development and to identify specific diagnostic and prognostic biomarkers that will
      improve the ability to accurately predict risk of AF development. The study will
      prospectively enroll patients with and without AF and determine their serum cytokine levels
      and assess the functional responses of T cells on the basis of cytokine production after in
      vitro T-cell specific stimulation, using Luminex bead-based multiplex technology.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 5, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cytokines Levels</measure>
    <time_frame>through study completion, approximately 3 years.</time_frame>
    <description>Cytokine Profiles</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Persistent AF</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Paroxysmal AF</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Psoriasis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Peripheral Blood Sample</intervention_name>
    <description>30mL peripheral whole blood sample</description>
    <arm_group_label>Persistent AF</arm_group_label>
    <arm_group_label>Paroxysmal AF</arm_group_label>
    <arm_group_label>Psoriasis</arm_group_label>
    <arm_group_label>Healthy Controls</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients 18 years and older.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cases: AF (Persistent, paroxysmal AF)

          -  Controls 1: (No prior history of AF or inflammatory or autoimmune diseases)

          -  Controls 2: (biopsy proven Psoriasis)

        Exclusion Criteria:

          -  Clinically apparent acute infections over the past 4 weeks

          -  Chronic infections

          -  Recent malignancies

          -  Recent Radiation or chemotherapy

          -  Chronic kidney disease (â‰¥ stage 2)

          -  Organ transplantation

          -  History of chronic liver disease

          -  Major surgery or invasive procedure in the past 6 months

          -  Internal prosthesis

          -  Receiving immunosuppressive therapy

          -  Known rheumatologic diseases (except for the participants with psoriasis)

          -  Females who are known to be pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rowlens M. Melduni, M.D., M.P.H.</last_name>
    <phone>(507) 538-0325</phone>
    <email>Melduni.Rowlens@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hannah Frost</last_name>
    <phone>(507) 293-2762</phone>
    <email>Frost.Hannah@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rowlens M. Melduni, M.D., M.P.H.</last_name>
      <phone>507-538-0325</phone>
      <email>Melduni.Rowlens@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2017</study_first_submitted>
  <study_first_submitted_qc>April 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2018</study_first_posted>
  <last_update_submitted>April 12, 2018</last_update_submitted>
  <last_update_submitted_qc>April 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Rowlens M. Melduni</investigator_full_name>
    <investigator_title>Consultant</investigator_title>
  </responsible_party>
  <keyword>Autoimmune Diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

